Getinge acquires Pennamed to strengthen endoscopy offering in the UK
Getinge today announces the acquisition of Pennamed, a UK-based distributor of endoscopic consumables serving National Health Service (NHS) and independent healthcare providers.
The acquisition strengthens Getinge’s offering to endoscopy units across the United Kingdom (UK) by combining Pennamed’s established consumables portfolio and strong customer relationships with Getinge’s expertise in endoscope reprocessing, infection control, and washer-disinfector technology.
Together, Getinge and Pennamed will support endoscopy teams across the UK Healthcare system with a broader and more integrated offering, helping to improve workflow efficiency, simplify procurement, and support compliance with infection control standards.
Endoscopy services in the UK continue to experience growing demand, driven by screening programmes and increasing procedure volumes. The combined portfolio of Getinge and Pennamed will enable healthcare providers to better manage these pressures while maintaining high standards of patient safety.
“We are delighted to welcome Pennamed to Getinge. This acquisition strengthens our ability to support UK endoscopy departments with a more complete and connected offering. By combining Pennamed’s consumables expertise with our reprocessing and infection control capabilities, we can deliver greater value to our customers and support the NHS in meeting increasing demand,” says Amy Rothwell, President UK & Ireland at Getinge.
“This deal provides a natural strategic home for the Pennamed business, bringing together Pennamed’s specialist endoscopic consumables portfolio with Getinge’s existing endoscopy footprint. This positions the company for continued growth and investment, while ensuring uninterrupted, high‑quality service for customers across the UK healthcare system” say shareholders of Pennamed, Ignatius and Kate Penna.
Getinge is strongly committed to the UK as both a key market and a strategic manufacturing base. With combined annual sales of approximately £130 million and close to 350 employees across Getinge and Pennamed, the UK represents an important part of Getinge’s global operations. The company’s site in Derby serves as a global centre of excellence for chemistry, supporting the continued development of infection control solutions worldwide.
Find out more about Getinge’s infection control solutions >>
Find out more about Pennamed >>
NB! This information is only intended for an audience in the UK.
Investor relations contact:
David Kördel, Head of Investor Relations
Phone: +46(0)10 335 0077
E-mail: david.kordel@getinge.com
Media contact:
Caroline Örmgård, Head of Media Relations
Phone: +46 (0)10 335 0041
Email: caroline.ormgard@getinge.com
About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.